TRACON PHARMACEUTICALS INC (TCON) Earnings History & Surprises

NASDAQ:TCON • US89237H3084

Current stock price

1.43 USD
-0.02 (-1.38%)
At close:
1.08 USD
-0.35 (-24.48%)
After Hours:

TCON Earnings overview

Past quarterly earnings results for TRACON PHARMACEUTICALS INC (TCON), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Aug 12, 2024
Period
Q2 / 2024
EPS Estimate
-$1.43
Revenue Estimate

Last Reported

Most Recent
Release Date
May 14, 2024
Period
Q1 / 2024
EPS Reported
-$1.33
EPS Surprise
-9.57%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
25%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q1 2024 -1.33 -1.21 -9.57% -269.44% 100K - -
Q4 2023 0.20 -1.63 112.25% 164.52% 3.045M 1.02M -100.00% -
Q3 2023 5.80 -1.33 537.41% 2,033.33% 3.621M -100.00% -
Q2 2023 4.40 -2.04 315.69% 1,519.35% 9M 2.295M 292.16% -
Q1 2023 -0.36 -0.27 -35.75% 25.00% - -
Q4 2022 -0.31 -0.28 -12.56% 22.50% - -
Q3 2022 -0.30 -0.29 -4.11% 21.05% - -
Q2 2022 -0.31 -0.38 18.41% 46.55% - -100.00%
Q1 2022 -0.48 -0.43 -12.72% -45.45% - -
Q4 2021 -0.40 -0.36 -11.14% -29.03% 58.283K -100.00% -
Q3 2021 -0.38 -0.33 -14.88% - 58.283K -100.00% -
Q2 2021 -0.58 -0.32 -82.59% 17.14% 346K - -
Q1 2021 -0.33 -0.31 -6.08% 57.69% - -
Q4 2020 -0.31 -0.41 25.14% - - -
Q3 2020 -0.38 -0.66 42.68% - - -
Q2 2020 -0.70 -0.74 5.56% - - -
Q1 2020 -0.78 -1.16 32.48% - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

TCON EPS Q2Q GrowthTCON EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 0 500 -500 1K 1.5K 2K

Revenue Historical Q2Q growth and Acceleration

TCON Revenue Q2Q GrowthTCON Revenue Q2Q GrowthRevenue Q2Q Growth Q2/22 Q2/24 -20 -40 -60 -80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
238.94%
Max EPS beat (4)
537.41%
Min EPS beat (4)
-9.57%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, TCON has beaten EPS estimates in 3 out of 4 releases
In the last 4 quarters, TCON has beaten the EPS estimates by 238.9% on average.
TCON Overview TCON Technical Analysis Report TCON Fundamental Analysis Report TCON Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

TRACON PHARMACEUTICALS INC / TCON Earnings FAQ

Can you provide the last earnings date for TRACON PHARMACEUTICALS INC?

TRACON PHARMACEUTICALS INC (TCON) last reported earnings on 5/14/2024.

Did TCON stock beat earnings estimates in the most recent quarter?

TRACON PHARMACEUTICALS INC (TCON) missed EPS estimates and missed revenue estimates in the most recent quarter.

How often does TRACON PHARMACEUTICALS INC (TCON) beat earnings estimates?

In the last 4 quarters, TRACON PHARMACEUTICALS INC (TCON) has beaten EPS estimates in 3 out of 4 releases.